1. Home
  2. APG vs BBIO Comparison

APG vs BBIO Comparison

Compare APG & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo APi Group Corporation

APG

APi Group Corporation

N/A

Current Price

$43.79

Market Cap

17.1B

ML Signal

N/A

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

N/A

Current Price

$79.81

Market Cap

15.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APG
BBIO
Founded
1926
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1B
15.9B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
APG
BBIO
Price
$43.79
$79.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
25
Target Price
$46.33
$86.33
AVG Volume (30 Days)
2.8M
2.0M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
17.86
N/A
EPS
0.32
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
$8.86
$89.45
Revenue Next Year
$6.04
$73.78
P/E Ratio
$135.84
N/A
Revenue Growth
N/A
126.26
52 Week Low
$33.40
$46.81
52 Week High
$49.99
$93.42

Technical Indicators

Market Signals
Indicator
APG
BBIO
Relative Strength Index (RSI) 66.49 45.74
Support Level $40.57 $78.90
Resistance Level $46.50 $85.34
Average True Range (ATR) 1.28 2.89
MACD 0.47 -0.63
Stochastic Oscillator 94.37 9.96

Price Performance

Historical Comparison
APG
BBIO

About APG APi Group Corporation

APi Group Corp operates in two segments: Safety Services segment includes providing safety services in North America, Asia Pacific, and Europe, focusing on end-to-end integrated occupancy systems (fire protection solutions, Heating, Ventilation, and Air Conditioning and entry systems), including design, installation, inspection, and service of these integrated systems. These services are provided in commercial, education, healthcare, high tech, industrial, and special-hazard settings. Specialty Services segment includes providing a variety of infrastructure services and specialized industrial plant services, which include maintenance and repair of critical infrastructure such as underground electric, gas, water, sewer, and telecommunications infrastructure.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: